Company: HURA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047921
Chunk: 364

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 364
---
    182,170

    Operating right-of-use assets

    199,160

    20,820

    Other noncurrent assets

    33,769

    -

    Total Assets
     
    $
    19,966,684

    $
    4,361,791

    Liabilities and Stockholders' Equity (Deficit)

    Current Liabilities:

    Accounts payable and accrued expenses
     
    $
    5,170,166

    $
    3,438,559

    Derivative liability

    -

    137,000

    Lease liabilities, current

    159,844

    20,820

    Total Current Liabilities

    5,330,010

    3,596,379

    Long-term Liabilities:

    Convertible notes payable, net

    -

    2,324,158

    Lease liability, long term

    42,698

    -

    Total Liabilities

    5,372,708

    5,920,537

    Stockholders' Equity (Deficit):

    Preferred Stock Series A (assumed in merger); $1.00 par value, 278,530 shares   outstanding as of December 31, 2024

    278,530

    -

    Preferred stock (Series A, A-1, and B) $0.001 par value; 16,912,843 authorized and   outstanding as of December 31, 2023; no shares issued and outstanding as of   December 31, 2024

    -

    16,913

    Common stock, $0.001 par value, 75,000,000 shares authorized as of   December 31, 2024; 42,323,759 and 12,167,679 shares issued and   outstanding as of December 31, 2024 and 2023.

    42,324

    12,168

    Additional paid in capital

    125,397,691

    86,887,170

    Accumulated deficit

    (111,124,569
    )

    (88,474,997
    )

    Total Stockholders' Equity (Deficit )

    14,593,976

    (1,558,746
    )

    Total Liabilities and